Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Las Palmas De Gran Canaria – page 18

322 clinical trials in Las Palmas De Gran Canaria, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Las Palmas De Gran Canaria at a glance
322
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

322 trials in Las Palmas De Gran Canaria

Open in trial search

Study Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Axatilimab
  • Sponsor:Incyte Corp.

Cardiac failure+1

Not recruiting

Study on CDR132L for Heart Failure with Reduced Ejection Fraction and Left Ventricular Hypertrophy in Adults

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

Study for Adults with Chronic Myeloid Leukemia Using Asciminib Alone or with Nilotinib

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Nilotinib
  • Sponsor:Fondazione G.I.M.Em.A Franco Mandelli Ets

Multiple sclerosis

Not recruiting

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis

Registered drug
Countries:SpainSpain
  • Participants:18–64 years
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Primary myelofibrosis

Not recruiting

Study of Momelotinib and Luspatercept for Patients with Transfusion-Dependent Myelofibrosis

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Luspatercept
  • Sponsor:Glaxosmithkline Research & Development Limited

Conjunctivitis allergic+1

Not recruiting

Study on the Safety and Effectiveness of Subcutaneous Immunotherapy with Der p 1, Der p 2, and Der p 23 Allergens for Patients with Allergic Rhinitis or Rhinoconjunctivitis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dermatophagoides Pteronyssinus
  • Sponsor:Diater Laboratorio De Diagnostico Y Aplicaciones Terapeuticas S.A.

Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acasunlimab
  • Sponsor:Genmab A/S

Study Comparing Elacestrant and Standard Endocrine Therapy for Patients with Early Breast Cancer at High Risk of Recurrence

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Stemline Therapeutics Inc.

Hidradenitis

Not recruiting

Study on the Effectiveness and Safety of Brensocatib for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Brensocatib
  • Sponsor:Insmed Inc.

Study of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Daiichi Sankyo Inc.

Study on Survival in Patients with Resectable Pancreatic Cancer Using Irinotecan, Fluorouracil, Calcium Folinate, and Oxaliplatin Combination Therapy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:La Fundacion Para La Gestion De La Investigacion Biomedica De Cadiz

Multiple sclerosis

Not recruiting

Study on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis

Investigational
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Frexalimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Spain

The busiest research cities in the country

All 210 cities in Spain

Clinical research in Las Palmas De Gran Canaria

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on multiple cancer types, including studies of novel therapeutic approaches for leukemia, lung cancer, and breast cancer.

  • BCR-ABL1+ Chronic Myeloid Leukemia treatments
  • Advanced bladder cancer therapies
  • Non-small cell lung cancer interventions

Research emphasizes combination therapies and targeted treatments to improve patient outcomes.

02 Autoimmune Conditions

Comprehensive studies investigating treatments for inflammatory diseases and autoimmune disorders, with particular focus on novel biological therapies.

  • Multiple sclerosis treatment innovations
  • Crohn's disease management
  • Ulcerative colitis therapies

Advanced clinical trials evaluating new therapeutic approaches for chronic inflammatory conditions.

03 Immunology Studies

Cutting-edge research in immunotherapy and allergic conditions, exploring new treatment modalities and therapeutic combinations.

  • Allergic rhinitis treatments
  • Graft-versus-host disease therapies
  • Immunotherapy combinations

Innovative approaches focusing on immune system modulation for various conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.